Valrocemide
Valrocemide, also known as TV-1901, is an antiepileptic drug (AED). Valrocemide has a broad spectrum of anticonvulsant activity and promising potential as a new AED. Valrocemide is an anticonvulsant agent under development by Teva and Acorda as a potential therapeutic for the treatment of epilepsy.
| Catalog Number | T3562 |
| Alternative Name(s) | TV1901 , N-Valproylglycinamide |
| Research Area | Others |
| Molecular Formula | C10H20N2O2 |
| CAS# | 92262-58-3 |
| Purity | 99.90% |
| SMILES | CCCC(CCC)C(=O)NCC(N)=O |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/Valrocemide |
| Additional Information | https://www.targetmol.com/datasheet/T3562 |